Navigation Links
Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
Date:8/19/2007

cancer, immune system disorders and ophthalmic disease. To advance the development and commercialization of its programs, Lexicon is working both independently and through collaborators including Bristol-Myers Squibb Company, Genentech, Inc. and N.V. Organon. For additional information about Lexicon and its programs, please visit http://www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX1031 and the potential therapeutic and commercial potential of LX1031. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX1031 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
2. Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
3. Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets
4. The Past, Present and Future of HLA Typing
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report describes ... veterinary medicine and pharmaceuticals as well as improvement ... important in the application of biotechnology to manage ...
(Date:8/4/2015)... 4, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX ... drivers of cancer, will be presenting at the 2015 Wedbush ... p.m. ET (10:55 a.m. PT) in New York ... and CEO of Mirati, will provide a corporate overview. ... accessible on the "Investors" page of Mirati,s corporate website at ...
(Date:8/4/2015)... IRVINE, Calif., Aug. 4, 2015  Syneron Medical Ltd. (NASDAQ: ... announced financial results for the three month period ended June ... Recent Non-GAAP 1 Highlights: , ... constant currency. , North American product sales grew 45% ... in constant currency, including 14% product growth in the EMEA ...
Breaking Medicine Technology:Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17
... Jan. 17, 2012 Positron Corporation (OTCBB: POSC), a ... nuclear cardiology is pleased to announce the acquisition of ... of the assets, business operations and retained all employees ... assumption of certain indebtedness and earn-out consideration of $3,500,000 ...
... Application helps researchers utilize bioinformatics tools ... and medical information products and services, today announced the ... SciVerse Applications . Created by OpenHelix , the ... of the genomics resources and tools used or cited ...
Cached Medicine Technology:Positron Finalizes Acquisition of Manhattan Isotope Technology, LLC 2Positron Finalizes Acquisition of Manhattan Isotope Technology, LLC 3Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications 2Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications 3Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications 4
(Date:8/4/2015)... ... August 05, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting more than 700,000 members and over 200 ...
(Date:8/4/2015)... ... August 04, 2015 , ... Statement by Paul Gionfriddo, President and CEO, Mental ... Mental Health Reform Act of 2015 by Senators Bill Cassidy and Christopher Murphy. ... in America. , “This legislation and H.R. 2646 [The Helping Families ...
(Date:8/4/2015)... ... August 04, 2015 , ... World Patent Marketing, a vertically ... a fitness invention that eliminates the need to have a partner or trainer ... industry is worth $30 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:8/4/2015)... ... August 04, 2015 , ... Atlantic Health System, one ... to Work® and Fortune among the top five in their list of the 20 ... Morristown, Overlook, Newton and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, is ...
(Date:8/4/2015)... Boca Raton, FL (PRWEB) , ... August 04, ... ... on-site diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, ... momentum but has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3
... March 11 CoreObjects is proud to announce ... Award" for their role in helping launch a product ... from diabetes. CoreObjects and their customer Piramal Healthcare shared ... the concept and development of the HbA1c Blood Sugar ...
... this week,s issue of the Journal of the American ... he and other physicians who worked in Haiti after the ... the face of a crushing wave of patients and inadequate ... the essay that the team of Johns Hopkins physicians that ...
... to the local store can end in getting lost, hurt, ... people with failing memories often keep driving, but a study ... even on familiar streets -- may be greater than once ... safe period behind the wheel because the disease is unpredictable, ...
... ... a Science of Consciousness" will be held April 22-23, 2010 in Madison, WI. , ... Madison, WI (PRWEB) March 11, 2010 ... Mirror: Toward a Science of Consciousness” will be held April 22-23, 2010 in Madison, WI. ...
... COLUMBUS, Ohio Cancer cells in rapidly growing brain ... die. When energy levels are high, tumor cells grow ... less and migrate more., Researchers at the Ohio State ... Richard J. Solove Research Institute have discovered the switch ...
... explaining to lawyers how hair alcohol testing works. , ... , , ... ... Care application orders increased by 46% ...
Cached Medicine News:Health News:CoreObjects Receives Project Management Institutes 'Excellence Award' for Diabetes Contribution 2Health News:Hopkins doctor/disaster expert says resource problems in Haiti required ethical decision-making 2Health News:Driving With Early Alzheimer's May Be Ill-Advised 2Health News:Driving With Early Alzheimer's May Be Ill-Advised 3Health News:"Consciousness" at 9th Annual International Bioethics Forum in Madison, Wisconsin 2Health News:Researchers discover brain tumor's 'grow-or-go' switch 2Health News:Researchers discover brain tumor's 'grow-or-go' switch 3Health News:Hair Alcohol Test Kit to Help in Third of Care Cases 2Health News:Hair Alcohol Test Kit to Help in Third of Care Cases 3
Next-generation real-time polymerase chain reaction (PCR) testing for clinical laboratories. , ,The COBAS TaqMan 48 Analyzer allows automated real-time amplification and detection of DNA or RNA f...
... for urologists by a urologist, ... screen technology to streamline your ... use of a cumbersome mouse. ... an EMR faster and better ...
... High-demand environments like OB/GYN, ER/Trauma, ... a glove that delivers precision and ... outstanding barrier protection. SAFESKIN* SATIN PLUS* ... more. Their smooth finish provides excellent ...
... CellaVision DM96 is an Automated Digital Cell ... pre-classification/characterization, display, storage and transmission of White ... 96 stained peripheral blood smears can be ... from 30 60 per hour depending ...
Medicine Products: